Dr. Reddy’s to acquire Slayback’s eyedrop rights
Pharma major Dr. Reddy’s Laboratories has entered into a licensing agreement to obtain rights to New Jersey-based Slayback Pharma’s Brimonidine Tartrate Ophthalmic Solution 0.025%.Slayback…
Quick News Bit